Allison Dorval

Allison Dorval is the current Chief Financial Officer at Verve Therapeutics. Prior to their current role, Allison served as the Vice President of Controller at Juniper Pharmaceuticals, Inc., the Chief Financial Officer at Voyager Therapeutics, Inc., and as a Consultant at Danforth Advisors.

Allison has significant experience in accounting, financial reporting, SEC compliance, Sarbanes-Oxley compliance, and tax compliance. Allison has also played a key role in multiple financing transactions and has managed the close process for several companies.

Allison's experience in the life sciences industry has allowed their to provide key financial and operational support to senior management teams, freeing them up to focus on driving science and technology value for their stakeholders.

Allison Dorval has a graduate certification in Taxation from Bentley University - McCallum Graduate School of Business, a Bachelor of Science in Accounting from University of Vermont, and is a Certified Public Accountant.

Some direct reports include Maggie Beaudoin - VP, Finance, Jennifer Robinson - VP, Investor Relations & Corporate Communications, and Nolan Yu - Senior Director, Financial Planning & Analysis. They work with Troy Lister - SVP, Research, Yasser El-Gamal - VP, Legal Affairs & Chief Intellectual Property Counsel, and Bryan Macdonald - Director, Pharmacology & Toxicology. Allison Dorval reports to Sekar Kathiresan, Co-Founder, CEO & Board Member.